Most of the results of the mid-term election are now in and can be reviewed on-line. Jeff Mervis at SCIENCE has a nice summer of what the changes in the House mean, here. My own sense is that with Eddie Bernice Johnson (D-TX) as the likely chair for House Science, the tenor of that Committee’s relationship with the non-biomedical US Science R&D agencies is going to improve significantly. Specifically with regards to Climate Change, and more generally with regards to a less adversarial oversight role. I think that’s probably a good thing.
NASA and probably also NSF lost a key advocate in John Culberson (R-TX) as chair of CJS, the appropriations committee responsible for the two agencies. On the other hand, NASA will probably be able to finesse the timing of when they send a probe to Europa and NSF’s contacts with Chinese science may be a bit less fettered (although the one from the White House is still pretty hawkish).
Barbara Comstock’s loss in Virginia is complex. While she could be a thorn in the side of NSF (e.g. NEON), she was extremely supportive of the DC metro area federal workforce and this benefited science agencies who depend on expert staff to keep the wheels moving.
My sense is that NIH is still coming out of this smelling like a rose. A more conservative senate may put the brakes on some hot-button research topics, but in general, I am pretty optimistic about the biomedical sector.
She was the President of the University of Chicago during the 1970’s and 80’s. She was also a consummate institutionalist in a way that some might think quaint in these days of social media-driven rage. Here’s a review of her recently published memoir which captures well this characteristic that is so rare among current academics. The operative metaphor is UC run as a modern-day Venetian Republic. Of course modern-day only in the sense of several decades ago and not during the Middle Ages.
Gray compares the University of Chicago’s elaborate governance structure to “the constitution of the Republic of Venice in the late medieval and early modern eras,” but praises it for “offering an invaluable means of garnering advice and discussion on all kinds of issues … with the faculty at large.” Of course, that matters only if one intends to work with one’s colleagues rather than one’s Twitter followers.
The Chandra X-ray telescope has also entered “safe mode”. However, worth pointing out that this instrument is well into its extended mission.
I know that we are waiting on the James Webb Space Telescope, but disturbingly, the Hubble Space Telescope is sitting in safe mode after a gyro failure this past weekend (hat tip to NASA watch). This is the telescope that has been the workhorse of NASA’s astronomy program.
In a sense this is the future. If we continue to send very complicated gadgets to technological edge environments, particularly in the near future with AI on-board, they are going to have to be much more resilient. Space and deep ocean are examples of such environments. There are implications for big science and DOD.
This story is a major scoop for Bloomberg. The geo-political significance has yet to fully play out. One question I have is who benefits from the story having been leaked. In any case, it constitutes a technological tour de force and probably a case of strategic surprise.
You know the drill: if you aren’t either first author or last author on a journal article in the life sciences, then you’re really not able to use that work as evidence of research independence when you come up for promotion or tenure. In this week’s Nature, Gretchen Kiser of UCSF rails against the semiotics of authorship order. Right now, I’m working on a manuscript in which all the authors are listed alphabetically with the asterisk denoting that we have all contributed equally. But that’s stuff and nonsense also: perfectly equal contributions to a work of scientific research is as rare as the Ivory Billed Woodpecker.
I don’t know what the solution to this mess is. As things stand our scientific identification (usually still denoted by our names) is the coin of the realm as far as credit and priority. Team science is indeed growing more common in many fields. As with Michael Lewis’ wonderful book on baseball, Moneyball, we may need new statistics to assess scientific excellence in the future.
I’m hearing a lot about NSF BIO’s new policy of one proposal per year for each Principal Investigator. In general, I’m hearing complaints from more senior investigators and positive interest from younger ones. This is somewhat counter-intuitive for me since I’d expect junior PI’s to be quite anxious to get as many proposals as possible in within the time window of their tenure clock. But I suppose they also see this new policy as potentially reducing the competition from the old fogies (an aside, this is the same logic of those who rejoice when NSF or NIH have funding downturns because they see those as driving out the competition).
In any case, I’m agnostic about this. It is certainly good that NSF is discouraging the recycling of proposal failures. I find it annoying that I can only be PI on one proposal for the coming year–although it will incentivize me to make it as excellent as possible. I do think that the rather negative report on this new policy in SCIENCE was insufficiently nuanced and would be happy to discuss with the reporter.